Biological Impact of Monoallelic and Biallelic BIRC3 Loss in Del(11q) Chronic Lymphocytic Leukemia Progression

被引:0
|
作者
Alamo, Miguel Quijada
Hernandez-Sanchez, Maria
Rodriguez, Ana E.
Carretero, Claudia Perez
Izquierdo, Marta Martin
Perez, Veronica Alonso
Garcia-Tunon, Ignacio
Bastida, Jose Maria
Vidal, Maria Jesus
DEL Canto, Josefina Galende
Aguilar, Carlos
Queizan, Jose Antonio
Marin, Isabel Gonzalez-Gascon Y.
Hernandez, Jose-Angel
Benito, Rocio
Ordonez, Jose Luis
Hernandez-Rivas, Jesus Maria
机构
关键词
D O I
10.1182/blood-2020-142658
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [11] BIRC3 loss accelerates leukemic progression through activation of the non-canonical NF-kB signaling of del(11q) CLL cells
    Quijada-Alamo, Miguel
    Luis Ordonez, Jose
    Hernandez Sanchez, Maria
    Eugenia Rodriguez-Vicente, Ana
    Martin-Izquierdo, Marta
    Hernandez Sanchez, Jesus M.
    Perez-Carretero, Claudia
    Maria Bastida, Jose
    Gonzalez, Teresa
    Garcia-Tunon, Ignacio
    Alonso-Perez, Veronica
    Benito, Rocio
    Wu, Catherine J.
    Maria Hernandez, Jesus
    LEUKEMIA & LYMPHOMA, 2020, 61 : 219 - 220
  • [12] Recurrent ATM and BIRC3 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) and Deletion 11q22-q23
    Grossmann, Vera
    Kohlmann, Alexander
    Schnittger, Susanne
    Weissmann, Sandra
    Jeromin, Sabine
    Kienast, Jennifer
    Kern, Wolfgang
    Haferlach, Torsten
    Haferlach, Claudia
    BLOOD, 2012, 120 (21)
  • [13] The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia
    Stankovic, Tatjana
    Skowronska, Anna
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1227 - 1239
  • [14] Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia
    Quijada-Alamo, Miguel
    Perez-Carretero, Claudia
    Hernandez-Sanchez, Maria
    Rodriguez-Vicente, Ana-Eugenia
    Herrero, Ana-Belen
    Hernandez-Sanchez, Jesus-Maria
    Martin-Izquierdo, Marta
    Santos-Minguez, Sandra
    Del Rey, Monica
    Gonzalez, Teresa
    Rubio-Martinez, Araceli
    Garcia de Coca, Alfonso
    Davila-Valls, Julio
    Hernandez-Rivas, Jose-Angel
    Parker, Helen
    Strefford, Jonathan C.
    Benito, Rocio
    Ordonez, Jose-Luis
    Hernandez-Rivas, Jesus-Maria
    CLINICAL AND TRANSLATIONAL MEDICINE, 2021, 11 (02):
  • [15] The Importance of IGHV Mutational Status in del(11q) and del(17p) Chronic Lymphocytic Leukemia
    Gladstone, Douglas E.
    Blackford, Amanda
    Cho, Eunpi
    Swinnen, Lode
    Kasamon, Yvette
    Gocke, Christopher D.
    Griffin, Constance A.
    Bolanos-Meade, Javier
    Jones, Richard J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (02): : 132 - 137
  • [16] The Prognostic Difference of Monoallelic Versus Biallelic Deletion of 13q in Chronic Lymphocytic Leukemia
    Orlandi, Ester M.
    Bernasconi, Paolo
    Pascutto, Cristiana
    CANCER, 2012, 118 (20) : 5179 - 5179
  • [17] Low prevalence and independent prognostic role of del(11q) in Chinese patients with chronic lymphocytic leukemia
    Zou, Yi-Xin
    Tang, Han-Ning
    Zhang, Jing
    Tang, Xiao-Lu
    Qin, Shu-Chao
    Xia, Yi
    Zhu, Hua-Yuan
    Qiao, Chun
    Wang, Li
    Fan, Lei
    Xu, Wei
    Li, Jian-Yong
    Miao, Yi
    TRANSLATIONAL ONCOLOGY, 2021, 14 (10):
  • [18] BIRC3 alterations in chronic and B-cell acute lymphocytic leukemia patients
    Alhourani, Eyad
    Othman, Moneeb A. K.
    Melo, Joana B.
    Carreira, Isabel M.
    Grygalewicz, Beata
    Vujic, Dragana
    Zecevic, Zeljko
    Joksic, Gordana
    Glaser, Anita
    Pohle, Beate
    Schlie, Cordula
    Hauke, Sven
    Liehr, Thomas
    ONCOLOGY LETTERS, 2016, 11 (05) : 3240 - 3246
  • [19] The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemia
    Garg, Ravin
    Wierda, William
    Ferrajoli, Alessandra
    Abruzzo, Lynne
    Pierce, Sherry
    Lerner, Susan
    Keating, Michael
    O'Brien, Susan
    CANCER, 2012, 118 (14) : 3531 - 3537
  • [20] Insulin Receptor Activation in Deletion 11q Chronic Lymphocytic Leukemia
    Brown, Jennifer R.
    CLINICAL CANCER RESEARCH, 2011, 17 (09) : 2605 - 2607